M&As CONTINUE TO CLICK, JUNE SEES 51 DEALS WORTH $5.35 BN

Amid apprehensions of economic slowdown, India Inc. seems to have resorted to mergers & acquisitions to keep their business going. The number of M&A deals announced in June stands at 51 with value at $5.35 billion, as against 49 deals and $2.92 billion in May...

The Economic Times

Japanese firm Daiichi to buy stake in Ranbaxy

Leading Japanese pharmaceutical firm Daiichi Sankyo Company Ltd, will acquire majority stake in India's largest drug maker Ranbaxy Laboratories Ltd. The companies have announced a binding share purchase and share subscription agreement (the "SPSSA") between Daiichi Sankyo, Ranbaxy and the Singh family, the largest and controlling shareholders of Ranbaxy.

Business Standard
http://www.business-standard.com/common/
storypage_c_online.php?leftnm=10&bKeyFlag=
IN&autono=39729